Bisphosphonate therapy in fibrous dysplasia

Fibrous dysplasia is proliferation of fibrous tissue within the bone marrow causing osteolytic lesions and pathologic fractures. Recently, second generation bisphosphonates have shown promise in the treatment of patients with fibrous dysplasia. In the current study, six patients with fibrous dysplas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical orthopaedics and related research 2001, Vol.382 (382), p.6-12
Hauptverfasser:	LANE, Joseph M, KHAN, Safdar N, O'CONNOR, William J, NYDICK, Martin, HOMMEN, Jan Pieter, SCHNEIDER, Robert, TOMIN, Emre, BRAND, Jordan, CURTIN, Janet
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Aged Alendronate - administration & dosage Alendronate - therapeutic use Biological and medical sciences Biomarkers - urine Bone and Bones - drug effects Bones, joints and connective tissue. Antiinflammatory agents Collagen - urine Collagen Type I Diphosphonates - administration & dosage Diphosphonates - therapeutic use Female Fibrous Dysplasia of Bone - diagnostic imaging Fibrous Dysplasia of Bone - drug therapy Follow-Up Studies Fractures, Spontaneous - prevention & control Humans Injections, Intravenous Male Medical sciences Middle Aged Osteogenesis - drug effects Osteolysis - prevention & control Pain Measurement Pamidronate Peptides - urine Pharmacology. Drug treatments Radiography Statistics, Nonparametric
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!